It seems like the midwest much prefers B2B software and health industry-focused startups. I'm assuming because they become profitable much faster and don't need the explosive growth and capital needs of moonshot SV companies. Fewer unicorn exits drops the EV of an investment, so you can't take as many risky bets.

I'd guess the medical startups are largely because of Cleveland Clinic and UPMC.